Braslyn Ltd. - Aug 10, 2021 Form 3 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role: 10%+ Owner
Signature: Braslyn Ltd., By: /s/ Jason Callender, Jason Callender, Director
Stock symbol: TNGX
Transactions as of: Aug 10, 2021
Transactions value $: $0
Form type: 3
Date filed: 1/4/2022, 04:00 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TNGX	Common Stock						27K	Aug 10, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are owned directly by Braslyn Ltd. ("Braslyn"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) Joseph C. Lewis, (v) BCTG Holdings, LLC, (vi) MVA Investors, LLC and (vii) Aaron I. Davis (collectively, the "Boxer Group"), and indirectly by Joseph C. Lewis who is the sole indirect beneficial owner of and controls Braslyn. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.

Content

These securities are owned directly by Braslyn Ltd. ("Braslyn"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) Joseph C. Lewis, (v) BCTG Holdings, LLC, (vi) MVA Investors, LLC and (vii) Aaron I. Davis (collectively, the "Boxer Group"), and indirectly by Joseph C. Lewis who is the sole indirect beneficial owner of and controls Braslyn. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.